2
1

SUPER BUGS Act of 2026

4/2/2026, 5:38 AM

Summary of Bill HR 7879

This bill, titled "To require the Secretary of State to formulate a strategy for the Federal Government to secure support for qualified pandemic or epidemic products," was introduced in the 119th Congress as H.R. 7879 on March 9, 2026. The bill aims to have the Secretary of State, in consultation with relevant departments, develop a strategy to obtain assistance from foreign countries and organizations to aid in the development and commercialization of pandemic or epidemic products.

Current Status of Bill HR 7879

Bill HR 7879 is currently in the status of Bill Introduced since March 9, 2026. Bill HR 7879 was introduced during Congress 119 and was introduced to the House on March 9, 2026.  Bill HR 7879's most recent activity was Referred to the House Committee on Foreign Affairs. as of March 9, 2026

Bipartisan Support of Bill HR 7879

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
3
Democrat Cosponsors
0
Republican Cosponsors
3
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 7879

Primary Policy Focus

Alternate Title(s) of Bill HR 7879

To require the Secretary of State, in consultation with the Secretary of Health and Human Services and other relevant departments and agencies, as appropriate, to formulate a strategy for the Federal Government to secure support from foreign countries, multilateral organizations, and other appropriate entities to facilitate the development and commercialization of qualified pandemic or epidemic products, and for other purposes.
To require the Secretary of State, in consultation with the Secretary of Health and Human Services and other relevant departments and agencies, as appropriate, to formulate a strategy for the Federal Government to secure support from foreign countries, multilateral organizations, and other appropriate entities to facilitate the development and commercialization of qualified pandemic or epidemic products, and for other purposes.

Comments